RhumbLine Advisers’s MedEquities Realty Trust, Inc. MRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-45,108
Closed -$502K 3065
2019
Q1
$502K Buy
45,108
+20
+0% +$216 ﹤0.01% 2329
2018
Q4
$308K Buy
45,088
+11,318
+34% +$88.8K ﹤0.01% 2533
2018
Q3
$328K Sell
33,770
-691
-2% -$7.32K ﹤0.01% 2471
2018
Q2
$380K Buy
34,461
+3,636
+12% +$37.5K ﹤0.01% 2431
2018
Q1
$324K Sell
30,825
-57
-0.2% -$606 ﹤0.01% 2396
2017
Q4
$346K Sell
30,882
-5,592
-15% -$63.4K ﹤0.01% 2394
2017
Q3
$429K Buy
36,474
+1,469
+4% +$17.4K ﹤0.01% 2386
2017
Q2
$442K Buy
35,005
+17,531
+100% +$210K ﹤0.01% 2365
2017
Q1
$196K Buy
17,474
+6,911
+65% +$77.1K ﹤0.01% 2655
2016
Q4
$117K Buy
+10,563
New +$118K ﹤0.01% 2777

RhumbLine Advisers's MRT Position: Q2 2019 in Review

RhumbLine Advisers sold out of MedEquities Realty Trust, Inc. (MRT) in Q2 2019, closing a stake of 45,108 shares — an estimated $502K sold.

RhumbLine Advisers first reported a position in MRT in Q4 2016 and held it in 10 quarters. The position peaked at $502K in Q1 2019. 0 funds tracked by Wall St. Rank hold MRT as of Q2 2019.

  • RhumbLine Advisers reported no remaining MedEquities Realty Trust, Inc. position as of Q2 2019 after selling out during the quarter.
  • RhumbLine Advisers sold 45,108 MedEquities Realty Trust, Inc. shares in Q2 2019, an estimated $502K.
  • RhumbLine Advisers first reported a position in MedEquities Realty Trust, Inc. in Q4 2016 and held it in 10 quarters.
  • RhumbLine Advisers's MedEquities Realty Trust, Inc. position peaked at $502K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held MedEquities Realty Trust, Inc. as of Q2 2019.

Based on RhumbLine Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.